abs332.txt	background		the	objective	of	this	study	was	to	demonstrate	feasibility	andefficacy	induction	chemotherapy	surgery	and	pathology-guided	adjuvanttherapy	treat	transorally	resectable	squamous	head	neck	cancer	methods	patients	had	that	by	thetransoral	route	advanced-stage	disease	(american	joint	committee	on	cancerstage	iii-iv	t3-t4	tumors	and/or	positive	lymph	nodes)	they	received	treatmentwith	weekly	carboplatin	at	an	area	under	curve	2	plus	paclitaxel135	mg/m2	daily	lapatinib	1000mg	for	6	weeks	followed	surgicalresection	pathology	revealed	margins	<5	mm	extracapsular	extension	n2a	ofn2b	node	status	perineural	invasion	or	lymphovascular	space	invasionresulted	in	adjuvant	radiotherapy	concurrent	with	cisplatin	pathologywith	n2c/n3	resulted	radiation	withbolus	primary	endpoint	clinical	response	rate	inductionchemotherapy	a	key	secondary	results	toxicity	modest	37	40	completed	procedures	asplanned	93%	pathologic	complete	responserate	36%	did	not	predict	completeresponse	no	patient	follow-up	has	recurred	died	twenty-nine	39patients	who	underwent	avoided	speech	swallowing	functionwere	well	preserved	conclusions	met	both	its	efficacy	secondaryfeasibility	neoadjuvant	systemic	therapy	surgical	resectionfollowed	risk-adapted	high	rates	andexcellent	long-term	outcomes	should	be	further	studied	cancer2018	124	2986-92	Â©	2018	american	society
